PepGen
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $130M
Investors
- 12
About PepGen
Founded in 2018 and headquartered in Cambridge, US, PepGen Inc. specializes in creating disease-modifying therapeutics targeting genetic conditions.PepGen specializes in the development of innovative disease-modifying therapeutics targeting genetic neuromuscular and neurological diseases. Their core offerings include proprietary molecules aimed at addressing the underlying causes of these conditions, emphasizing therapies that can modify disease progression through targeted interventions. By utilizing advanced genetic therapy techniques, PepGen strives to deliver effective treatments for patients suffering from serious conditions, with a focus on neuromuscular disorders such as muscular dystrophies and spinal muscular atrophy.PepGen's revenue model primarily relies on collaborations and partnerships within the pharmaceutical and biotechnology sectors, focusing on B2B transactions. They engage with healthcare providers, research organizations, and potentially other pharmaceutical firms to facilitate the distribution of their therapeutics. Revenue is expected to increase following successful clinical trial outcomes leading to product approvals, which would enable the commercialization of their proprietary therapies.PepGen Inc. plans to expand its product line with new therapeutics targeting genetic neuromuscular diseases, with potential launch dates to be determined based on clinical trial results. The company is also exploring expansion into European markets, aiming for a rollout by 2025. Additionally, CureDuchenne Ventures, Deerfield Management, Gray's Creek Capital Partners, and Tudor Investment Corporation have exited their stake in PepGen Inc. for an undisclosed amount, indicating a strategic shift in the company's investment landscape.
Who invested in PepGen
12 investors across 3 rounds
See all investors in PepGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PepGen
Who invested in PepGen?
PepGen has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PepGen raised?
PepGen has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did PepGen last raise money?
PepGen's most recent round on record is a Series B, in Jul 2021.
What does PepGen do?
Founded in 2018 and headquartered in Cambridge, US, PepGen Inc.
Where is PepGen headquartered?
PepGen is headquartered in Cambridge, US.
Which VCs invest in companies like PepGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PepGen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like PepGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.